Assuntina G. Sacco, Md

This study is testing if a drug called pembrolizumab can help people with recurrent head and neck cancer stay cancer-free for longer after a second surgery. The drug is an immunotherapy designed to help the body's own immune system fight the cancer. Researchers will give the drug…